Search research articles
Contact Us
Filters
Showing results (31-40 of 196) with videos related to
Page
of 20
Sort By:
Journal of Medicinal Chemistry
|
April 20, 2001
Effect of N-alkyl and N-alkenyl substituents in noroxymorphindole, 17-substituted-6,7-dehydro-4,5alpha-epoxy-3,14-dihydroxy-6,7:2',3'-indolomorphinans, on opioid receptor affinity, selectivity, and efficacy
S McLamore, T Ullrich, R B Rothman, et al.
European Journal of Radiology
|
April 1, 2019
Analysis of PI-RADS 4 cases: Management recommendations for negatively biopsied patients
T Ullrich, C Arsov, M Quentin, et al.
Cancer Research
|
March 29, 2014
Transient antiangiogenic treatment improves delivery of cytotoxic compounds and therapeutic outcome in lung cancer
Sampurna Chatterjee, Caroline Wieczorek, Jakob Schöttle, et al.
Cancers
|
October 14, 2022
Trophoblast Cell Surface Antigen 2 (TROP2) as a Predictive Bio-Marker for the Therapeutic Efficacy of Sacituzumab Govitecan in Adenocarcinoma of the Esophagus
Sascha Hoppe, Lydia Meder, Florian Gebauer, et al.
Molecular Metabolism
|
September 21, 2020
Hepatic FTO is dispensable for the regulation of metabolism but counteracts HCC development in vivo
Melanie J Mittenbühler, Katarzyna Saedler, Hendrik Nolte, et al.
European Radiology
|
November 8, 2021
MRI grading for the prediction of prostate cancer aggressiveness
M Boschheidgen, L Schimmöller, C Arsov, et al.
Magnetic Resonance Imaging
|
February 12, 2025
Use of deep learning-accelerated T2 TSE for prostate MRI: Comparison with and without hyoscine butylbromide admission
M Boschheidgen, L Drewes, B Valentin, et al.
European Journal of Radiology
|
December 24, 2021
Comparison of 3 T mpMRI and pelvic CT examinations for detection of lymph node metastases in patients with prostate cancer
B Valentin, C Arsov, T Ullrich, et al.
Scientific Reports
|
April 26, 2022
Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate
M Boschheidgen, L Schimmöller, S Doerfler, et al.
Data in Brief
|
November 25, 2022
Data on the detection of clinically significant prostate cancer by magnetic resonance imaging (MRI)-guided targeted and systematic biopsy
M Klingebiel, C Arsov, T Ullrich, et al.
Page
of 20
Search research articles
Search
Showing results (31-40 of 196) with videos related to
Sort By:
Page
of 20
Journal of Medicinal Chemistry
|
April 20, 2001
Effect of N-alkyl and N-alkenyl substituents in noroxymorphindole, 17-substituted-6,7-dehydro-4,5alpha-epoxy-3,14-dihydroxy-6,7:2',3'-indolomorphinans, on opioid receptor affinity, selectivity, and efficacy
S McLamore, T Ullrich, R B Rothman, et al.
European Journal of Radiology
|
April 1, 2019
Analysis of PI-RADS 4 cases: Management recommendations for negatively biopsied patients
T Ullrich, C Arsov, M Quentin, et al.
Cancer Research
|
March 29, 2014
Transient antiangiogenic treatment improves delivery of cytotoxic compounds and therapeutic outcome in lung cancer
Sampurna Chatterjee, Caroline Wieczorek, Jakob Schöttle, et al.
Cancers
|
October 14, 2022
Trophoblast Cell Surface Antigen 2 (TROP2) as a Predictive Bio-Marker for the Therapeutic Efficacy of Sacituzumab Govitecan in Adenocarcinoma of the Esophagus
Sascha Hoppe, Lydia Meder, Florian Gebauer, et al.
Molecular Metabolism
|
September 21, 2020
Hepatic FTO is dispensable for the regulation of metabolism but counteracts HCC development in vivo
Melanie J Mittenbühler, Katarzyna Saedler, Hendrik Nolte, et al.
European Radiology
|
November 8, 2021
MRI grading for the prediction of prostate cancer aggressiveness
M Boschheidgen, L Schimmöller, C Arsov, et al.
Magnetic Resonance Imaging
|
February 12, 2025
Use of deep learning-accelerated T2 TSE for prostate MRI: Comparison with and without hyoscine butylbromide admission
M Boschheidgen, L Drewes, B Valentin, et al.
European Journal of Radiology
|
December 24, 2021
Comparison of 3 T mpMRI and pelvic CT examinations for detection of lymph node metastases in patients with prostate cancer
B Valentin, C Arsov, T Ullrich, et al.
Scientific Reports
|
April 26, 2022
Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate
M Boschheidgen, L Schimmöller, S Doerfler, et al.
Data in Brief
|
November 25, 2022
Data on the detection of clinically significant prostate cancer by magnetic resonance imaging (MRI)-guided targeted and systematic biopsy
M Klingebiel, C Arsov, T Ullrich, et al.
Page
of 20